Have We Learned How to Talk About GLP1s?
An estimated one in eight Americans has now tried a GLP-1 medication like Ozempic or WeGovy: to lose weight, manage diabetes or experiment with anecdotal, off-label benefits. Yet GLP-1s can be hard to talk about — whether you want to ask someone if they take one, respond if you do, or discuss weight without dredging up unhealthy diet discourse. We’ll hear how you’re navigating these conversations in the age of GLP-1s. Tell us: How are GLP-1s showing up in your world? Guests: Diana Thiara, medical director, UCSF Weight Loss Management Program Whitney Casares, pediatrician; author, “Raising…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.